Sanofi | SNY - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 41.64B 458M 2026-06
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Drreddys Laboratories INR 167.57B 165.8B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Genmab DKK 1.43B 686M 2025-12
GlaxoSmithKline GBP 21.53B 895M 2026-06
Glaxosmithkline GBP 22.43B 6.39B 2026-03
J&J USD 54.9B 2.82B 2026-06
Lakefront Biotherapeutics EUR 100.42M 52.44M 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.75B 374M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 32.65B 1.7B 2026-06
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 120.92M 18.63M 2026-03
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Sanofi EUR 30.01B 1.66B 2026-03
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
UCB EUR 4.4B 470M 2025-12
Zoetis USD 2.05B 182M 2026-03